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A B S T R A C T
A 30-year old man presented with symptoms and signs of acute appendicitis. Abdomi-
nal imaging via ultrasound and computed tomography detected a mass in the right 
iliac fossa. Exploratory laparotomy revealed an appendiceal mass and gelatinous peri-
toneal fluid, while histopathology confirmed the diagnosis of pseudomyxoma perito-
nei arising from a mucocele of the appendix and attributed to an appendiceal cystade-
nocarcinoma. The clinical and imaging findings of this rare case are herein presented.
I N T R O D U C T I O N
Pseudomyxoma peritonei is an uncommon clinical condition, characterized by ac-
cumulation of thick, gelatinous material in the peritoneal cavity.1 Its estimated incidence 
is 1-2 per million per year, predominantly affecting women (2-3:1 compared to men).2 
Although it constitutes a clinical rather than a histopathological diagnosis,1,3 in the 
majority of cases it is thought to originate from an appendiceal mucinous neoplasm,4 
forming a mucocele of the appendix, which later perforates or ruptures, disseminating 
its mucinous contents into the peritoneal cavity.2 We herein report a case of pseudo-
myxoma peritonei describing the clinical and imaging findings. 
C A S E  R E P O R T
A 30-year old man presented with one-month history of mild epigastric and right 
iliac fossa pain. Over the preceding two weeks, the pain also radiated to his right 
shoulder. On physical examination, there was tenderness in the right lower quadrant, 
but no rebound tenderness. There was mild abdominal distention but no definite mass 
could be palpated and no apparent shifting dullness could be elicited. Laboratory 
findings included an elevated C-reactive protein (7.3 mg/dL; normal values <0.3 mg/
dL), leukocytosis (white blood cell count of 11,230/μL; normal values 4,000-10,500/
μL) and elevated lactic dehydrogenase (371 IU/L; normal values <255 IU/L). Chest 
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x-ray revealed a small right pleural effusion. The patient was 
subsequently scheduled for an abdominal ultrasound and 
contrast-enhanced computed tomography (CT) examination. 
Abdominal ultrasound demonstrated a mass of mixed 
echogenicity in the right iliac fossa, ascites with solid echo-
genic components which did not move after changing patient’s 
position (Fig. 1 & 2), as well as free pleural fluid on the right 
side. Contrast-enhanced CT of the abdomen confirmed a 10 
cm right iliac fossa mass containing a few calcifications and 
mildly enhancing post contrast injection, scalloping of the liver 
margins, ascites with solid components and right-sided pleural 
effusion with accompanying atelectasia of the adjacent lung 
parenchyma (Fig. 3, 4 & 5). 
The patient was initially treated surgically with appen-
dectomy and debulking of the peritoneal gelatinous material. 
FIgURE 1. Abdominal ultrasound imaging revealed ascites with 
solid echogenic components (arrow).
FIgURE 2. Abdominal ultrasound showed a mass of mixed 
echogenicity in the right iliac fossa (arrows).
FIgURE 4. Contrast-enhanced abdominal CT revealing a 10-cm 
right iliac fossa mass (between the two arrows) with a few cal-
cifications, mildly enhancing post contrast injection, displacing 
adjacent bowel loops.
FIgURE 3. Contrast-enhanced abdominal CT showed scallop-
ing of the liver contour (upper arrow), ascites and right-sided 
pleural effusion with accompanying atelectasia of the adjacent 
lung parenchyma (lower arrow). 
Post-surgery histopathology reported pseudomyxoma perito-
nei, arising from a mucocele of the appendix and attributed 
to an appendiceal cystadenocarcinoma. After pathological 
confirmation of the disease, the patient was referred to a spe-
58
HOSPITAL CHRONICLES 7(1), 2012
cialized center for further management to include cytoreduc-
tive surgery and hyperthermic intraperitoneal chemotherapy. 
D I S C U S S I O N
As was the case with this patient’s clinical presentation, 
pseudomyxoma peritonei in early stages presents with vague 
abdominal pain or localized symptoms manifesting as appen-
dicitis. In more advanced stages it presents with the typical 
distended “jelly belly”, due to ascites and, in some cases, 
intestinal obstruction, secondary to compression of the bowel 
from the tumor and ascites.2 
Imaging findings reflect the presence of massive ascites 
with increased opacity throughout the abdomen and poor 
definition of the borders of intraabdominal organs and the 
psoas muscles. Occasionally, there is medial displacement of 
the liver tip (Hellmer sign) or the ascending and descending 
colon, as well as faint, curvilinear or amorphous calcifications.5 
Ultrasound features of pseudomyxoma peritonei include asci-
tes with echogenic, immobile elements, reflecting its gelatinous 
nature. Ascites may contain septa representing mucinous 
nodules and focal or sheetlike echogenic masses due to in-
volvement of the omentum and parietal peritoneum. Bowel 
loops are displaced by the surrounding material centrally and 
posteriorly, often presenting with a characteristic “starburst” 
appearance.6 Characteristic ultrasound and CT findings also 
include scalloping of the hepatic and splenic margins, caused 
by adjacent intraperitoneal masses. Mucin within the perito-
neal cavity shows low attenuation on CT. However, soft-tissue 
attenuation areas may also be seen, representing solid tumor 
masses, fibrosis or compression of the mesentery. Calcifica-
tions, if present, are also evident on CT.5
Magnetic resonance imaging (MRI) findings include peri-
toneal implants of low signal intensity in T1-weighted images, 
high signal intensity in T2-weighted images (especially in the 
center), peripheral enhancement after injection of paramag-
netic contrast medium, as well as restricted diffusion.7 It has 
been proposed that MRI has an advantage over CT in detecting 
microcystic lesions, as well as in depicting small bowel obstruc-
tion by means of magnetic resonance enteroclysis imaging.8,9 
Even though not all the imaging findings of pseudomyxoma 
peritonei reported in the literature were illustrated in the 
ultrasound and CT examination of our patient, the presence 
of ascites with immobile solid components, liver scalloping, 
peritoneal implantations and peripheral calcifications were 
all indicative of the disease (Fig. 1-5).
Disseminated adenomucinosis, peritoneal carcinomatosis 
and peritoneal mesothelioma are the main types of peritoneal 
surface malignancies, which may present with features of pseu-
domyxoma peritonei. Adenocarcinoma of the gastrointestinal 
tract and ovarian neoplasms are other common conditions, 
which may mimic the clinical presentation, radiological fea-
tures and operative findings of pseudomyxoma peritonei.9 
Current treatment of choice includes aggressive cytore-
ductive surgery, parietal peritonectomy and excision of the 
involved viscera combined with intraperitoneal chemotherapy 
with hyperthermia, as well as systemic chemotherapy. This 
combination is deemed to yield better results in comparison 
to past treatment of serial surgical debulking.2,3,10,11 
Prognosis of pseudomyxoma peritonei depends on the 
extent of peritoneal seeding11 and the histological grade of the 
neoplasm.2,3,11 Successful treatment in low-grade neoplasms 
after complete cytoreduction can be as high as 73-80%.2,3,11 
In conclusion, pseudomyxoma peritonei is an uncommon 
entity presenting with atypical clinical symptoms, sometimes 
mimicking acute appendicitis, as in the present case. Imag-
ing findings can aid in establishing the diagnosis and guiding 
surgical treatment.
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